Pfizer India Q2 profit rises 65.6% on ₹132 crore gain
In short
Pfizer India reported Q2 net profit of ₹313 crore, up 65.6% year on year. Revenue rose 13.2% to ₹727 crore, and the quarter included a one-time gain of ₹132 crore.
The stock rose 5% after the update. It is not stated how much of the profit jump was due to normal business versus the one-time gain.
What the reporting says
Pfizer India reported a 65.6% year-on-year rise in Q2 net profit to ₹313 crore, with revenue up 13.2% to ₹727 crore. The quarter included a one-time gain of ₹132 crore, while EBITDA rose 14.4% to ₹262 crore and the margin stayed flat at 36%. The immediate market reaction was a 5% rise in the stock, but the sustainability of earnings is not stated.
Why it matters
Pfizer India reported stronger Q2 numbers, with profit, revenue and EBITDA all higher year on year. The quarter also had a ₹132 crore one-time gain, which likely supported the profit jump. The stock rose 5% after the update, but the reporting does not say whether investors expect the earnings strength to continue beyond this quarter.